Skip to main content
Cambridge University Press - PMC COVID-19 Collection logoLink to Cambridge University Press - PMC COVID-19 Collection
. 2021 May 19:1–13. doi: 10.1017/dmp.2021.154

Volcanic Ash as a Precursor for SARS-CoV-2 Infection Among Susceptible Populations in Ecuador: A Satellite Imaging and Excess Mortality-Based Analysis

Theofilos Toulkeridis 1,2,, Rachid Seqqat 1, Marbel Torres Arias 1, Rodolfo Salazar-Martinez 1, Esteban Ortiz-Prado 3, Scarlet Chunga 4, Karla Vizuete 1, Marco Heredia-R 5, Alexis Debut 1
PMCID: PMC8314306  PMID: 34006342

Abstract

The global coronavirus disease 2019 (COVID-19) pandemic has altered entire nations and their health systems. The greatest impact of the pandemic has been seen among vulnerable populations, such as those with comorbidities like heart diseases, kidney failure, obesity, or those with worse health determinants such as unemployment and poverty. In the current study, we are proposing previous exposure to fine-grained volcanic ashes as a risk factor for developing COVID-19. Based on several previous studies it has been known since the mid 1980s of the past century that volcanic ash is most likely an accelerating factor to suffer from different types of cancer, including lung or thyroid cancer. Our study postulates, that people who are most likely to be infected during a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) widespread wave will be those with comorbidities that are related to previous exposure to volcanic ashes. We have explored 8703 satellite images from the past 21 y of available data from the National Oceanic and Atmospheric Administration (NOAA) database and correlated them with the data from the national institute of health statistics in Ecuador. Additionally, we provide more realistic numbers of fatalities due to the virus based on excess mortality data of 2020-2021, when compared with previous years. This study would be a very first of its kind combining social and spatial distribution of COVID-19 infections and volcanic ash distribution. The results and implications of our study will also help countries to identify such aforementioned vulnerable parts of the society, if the given geodynamic and volcanic settings are similar.

Keywords: COVID-19, volcanic ash, pulmonary and thyroid vulnerability, spatial spreading wave of infection, excess mortality


The coronavirus disease 2019 (COVID-19) pandemic has rapidly expanded around the globe. Latest figures from February 2021 show that more than 111 million cases and more than 2.5 million deaths have been officially reported worldwide.1,2 Infections have been detected in every human group, affecting men and women from all ages, being more lethal for elderly people and those with previous health conditions, such as cardiac problems, diabetes, obesity, and other preconditions.3 Based on the worldwide reported cases of all countries, current evidence indicates that the primary mode of transmission of COVID-19 is through direct contact through respiratory droplets that can be projected at varying distances, COVID-19 begins to be distributed mainly by contacts of 1 person to another by aerosols, and potentially by touching contaminated surfaces (ie, fomites).4 This infection travels by air, forming droplets with an estimated diameter of 5 to 10 micrometers (µm), and also through droplet nuclei, whose diameter is less than 5 µm.5,6 As larger droplets are pulled to the ground rapidly by gravity, transmission of the droplets requires close physical proximity between infected and susceptible individuals, whereas aerosol transmission can occur over greater distances and does not necessarily require that individuals infected as well as susceptible ones are in the same place in the same environment and places like hospitals.

Studies have demonstrated that respiratory droplets can be projected up to 2 meters.7 In 1 study, droplets were found on the floor up to 4 meters from a patient.8 A systematic review of studies evaluating the horizontal distance traveled by respiratory droplets found that droplets could travel over 2 meters and up to 8 meters.9 Environmental exposures, such as sunlight, can have significant effects on the viability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a rotating drum experiment similar to other studies on the viability of SARS-CoV-2, simulated sunlight (UVA/UVB) was applied to an aerosolized virus through a window of the drum. Results indicated that 90% of viruses are inactivated within 20 min in indoor settings, which poses a higher risk of transmission.10

Epidemiological studies on the transmission of COVID-19 to thousands of secondary contacts in households have determined infection rates ranging from 7 to 23%. For close contacts outside the household, secondary infection rates are less than 1%.1113 The transmission limited to contact outside the household suggests that the mode of transmission of COVID19 is not by air. The reproduction rate (R0) is less suggestive of airborne spread, because airborne infections tend to have a higher R0. For example, in a systematic review,14 The R0 for measles before vaccination was 6.1 to 27.0, compared with the range of R0 (2 to 3) reported for COVID-19.15

In Ecuador, the official patient zero of COVID-19 appeared in February 2020 and created a first hotspot and a rapid contamination of a high amount of people with corresponding high death rate in Guayaquil and the corresponding province of Guayas, due to a variety of social and political circumstances. Since then, the mortality rate dramatically increased initially at the end of March, although a strict lockdown was imposed by the governmental authorities on March 16. Due to the difficult economic situation even prior the declaration of the pandemic, due to low oil prices, fatal policies, as well as consequences of a variety of past natural disasters, a stepwise revocation of the lockdown on May 4, allowed local migration and business activities, which inflated once again the virus-spreading situations in urban and rural areas.1621 (REF). Therefore, Ecuador officially has had the highest death rate by far in South America when compared with deaths per million citizens up to end of June 2020. Additionally, the number of some 6000 fatalities representing around 370 deaths per million citizens, may be most likely much worse, as various media reported of a surplus of 25 thousands fatalities for the same period of time (March-August 2020).2226 This would result for approximately 1765 deaths per million citizens, having to be unofficially the highest rate worldwide for that period of time. Sincethen, the death toll continued, but not at the same acceleration as previously to spring-summer of 2020 (Table 1).1,2,27

Table 1.

Mortality and excess mortality rates of Ecuador between 2018 and 2021a

Month 2018 2019 2020 2021 Avg
2018-19
Avg
2018-20
Excess mortality Official COVID mortality Excess mortality and
official COVID mortality
January 6696 6706 6699 8454 6700,3 1753,7 813 940,7
February 5751 5930 6057 7652 5840,5 216,5 / 1811,5 0 / 949 216,5 / 862,5
March 6057 6570 10030 10241 6313,5 3716,5 / 3927,5 116 / 1020 3600,5 / 2907,5
April 5778 6159 20977 5968,5 15008,5 1180 13828,5
May 5883 5960 10111 5921,5 4189,5 3847 342,5
June 5758 5891 8997 5824,5 3172,5 1828 1344,5
July 5977 6078 10845 6027,5 4817,5 1835 2982,5
August 6104 6245 10055 6174,5 3880,5 1327 2553,5
September 5814 6194 7991 6004,0 1987,0 1105 882,0
October 5938 5976 7557 5957,0 1600,0 1312 288,0
November 5799 6010 7321 5904,5 1416,5 783 633,5
December 6427 5712 7137 6069,5 1067,5 565 502,5
Total 71982 73431 113777 48565,2 16680 31885,2
a

Based on John Hopkins Coronavirus Research Center, 20211; Worldometer, 20212; Instituto Nacional de Estadistica y Censo, 2021.27 Data of February and March correspond to 2020 and 2021.

Therefore, by such circumstances given by the mortality rate in Ecuador, the calculated contagion amount is much higher than the official numbers realized by the national Ministry of health. If the excess mortality has reached more than 45,000 citizens for the period between March 2020 and March 2021, while the official mortality by COVID-19 has been slightly less than 17,000 by end of March 2021, than we assume that the contagion is also much higher than the officially stated around 310,000 for the same period of time. When taking into account that in all official worldwide statistics, there has been a contagion/mortality rate of 2.18%, then the calculated amount of contagion persons in Ecuador will be of at least 2.228 million citizens by the end of March 2021. This corresponds more than 12.4% of the total population of the country. Additionally, based on these calculations of the excess mortality, the deaths per 1 million citizens would reach a rate of approximately 2720, being hereby slightly lower than the top country of Gibraltar in this official statistic with a rate of 2791 (Figure 1).1,2 Based on such calculations and the aforementioned circumstances of different ways of contagion, it is a matter of simple arithmetic before a nationwide successful vaccination, to preview, that the health of the entire country´s population will be compromised in a variety of degrees.

Figure 1.

Figure 1.

Comparison of official COVID mortality and excess mortality in Ecuador from February 2020 up to March 2021.

Taken the aforementioned into consideration, it is of the outermost priority to establish which parts of the general population may be most certain affected and hereby strongly confronted by a potential infection by COVID-19. Generally, as demonstrated statistically by a variety of studies, persons who most likely got infected with this virus have been having previous health conditions, such as those with cardiac or diabetic issues, pulmonary weaknesses, obese persons, smokers, and elderly persons. Among people with several other similar fragilities or debilities, having with respect to COVID-19 a higher infection and death rate, will be those parts of the population who will need to be in the first priority to be protected based on their high vulnerability.

One of the most underestimated respirable natural hazards is the emission of volcaniclastic material in the form of fine-grained volcanic ash. While the precipitation of such material does not necessarily lead to direct death, death can occur in masses caused by asphyxiation or to physical damage due to roof collapse.2830 Volcanic ash is known to provoke severe pulmonary problems, such as bronchitis and asthma (Figure 2), and usually minor health issues, such as ocular, nasal, throat, and skin irritation.3137 In addition to pulmonary issues, evidence shows that the emission of volcanic ash generates a higher rate of thyroid cancer.3840 In this respect, compared with other countries around the planet in general and those with volcanic activity in particular, Ecuador, which has a strong volcanic activity in its territory, has the worldwide highest rate of thyroid cancer41,42 (Figure 2). This finding is evidence that the presence of volcanic ash leads to a variety of pulmonary and thyroid weaknesses, making affected people more prone to a higher than regular vulnerability toward COVID-19 infections.

Figure 2.

Figure 2.

Activation of the inflammatory protein complex in lung cells due to infection with the SARS-CoV-2 virus and possible complications from inhalation of volcanic ash in lung cells and secretion of cytokines that cause inflammation.

Consequently, the current study will allow a new focus on the projection of so far unknown weaknesses of a great part of the Ecuadorian population who lives in areas, which are susceptible to COVID-19, as there an essential part of the population who has been diagnosed with or highly vulnerable to thyroid cancer, a disease that is related to chronic respiratory diseases, which itself is most likely related to the function of the precipitation of volcanic ash. Therefore, we will identify areas, and the corresponding living populations within that are highly exposed to the emissions and fallout of fine-grained volcanic material. People in these areas are, therefore, more likely to be susceptible to and preferentially affected by the SARS-CoV-2 virus. Once such areas are detected, then more detailed and specific preventive measures should be implemented and with particular epidemiological monitoring.

Results and Discussion

Worldwide Evolution of COVID-19

The SARS-CoV-2 causing COVID-19 has reached pandemic levels since March 2020.43 In the absence of vaccines or curative medical treatment, COVID-19 exerts a huge global impact on public health and health-care delivery. SARS-CoV-2 not only causes viral pneumonia but has major implications for the cardiovascular CV system.44 Patients with CV risk factors, including male sex, advanced age, diabetes, hypertension, and obesity, as well as patients with established CV and cerebrovascular disease, have been identified as particularly vulnerable populations with increased morbidity and mortality when suffering from COVID-19.45

Viral respiratory infections represent a very significant part of the morbidity observed in the patient and remain the main cause of death from infectious agents. This route of transmission remains a major source of global pandemics due to rapid human-to-human transmission through the respiratory tract.46 The myocardial damage by means of the receptor for the angiotensin converting enzyme 2 (ACE2), which cardiomyocytes express in a significant amount. This could be the cause of true myocarditis; according to Ruan et al.,47 the SARS-CoV viral RNA was detected in 35% of human hearts autopsied during the SARS epidemic. This shows that SARS-CoV can cause ACE2-dependent myocardial infarction.

ACE2 is an enzyme of the renin angiotensin system (RAS) that is expressed on the cell surface of many tissues including brain, heart, kidney, and type 2 alveolar epithelial cells in the lungs. It is defined as the receptor for the SARS-CoV-2 spike protein, and affect to host cells, however, the affinity of SARS-CoV-2 for ACE2 is 10- to 20-fold higher than that of SARS-CoV, and induce a high transmissibility.48

ACE2 converts angiotensin II (Ang II) into Ang-1 to -7, that lowers blood pressure with vasodilation and by promoting kidney sodium and water excretion.49 ACE2 shares approximately 60% homology with ACE. ACE converts Ang I into Ang II, which acts at the type 1 angiotensin receptor (AT1R) by increasing blood pressure and inducing vasoconstriction, increasing kidney reabsorption of sodium and water, and increasing oxidative stress to promote inflammation and fibrosis.50

Although clinical manifestations are dominated by respiratory symptoms up to acute respiratory distress syndrome (ARDS), the virus has a double cardiovascular impact: on the one hand, the infection will be more intense if the host has comorbidities (cardiovascular disease) and, on the other hand, the virus can by itself cause life-threatening cardiovascular damage. Several data had shown that Middle East respiratory syndrome coronavirus (MERS-CoV) could be the cause of acute myocarditis.51 Data obtained from patients infected with SARS-CoV and monitored over a 12-y period argue in favor of a deregulation of lipid metabolism induced by the virus, which could be at the origin of an increase in events long-term cardiovascular disease in survivors without the mechanism being identified at this time.52

People with diabetes have impaired immune-response to infection both in relation to cytokine profile and to changes in immune-responses, including T-cell and macrophage activation,53 and are at increased risk of infections, including influenza, and for related complications, such as secondary bacterial pneumonia, many patients with diabetes can be in poor metabolic control when infected by COVID-19. Poor glycemic control impairs many aspects of the immune response to viral infection that lead to infection in the lungs.54 In most cases, diabetes is associated with obesity that is a risk factor for severe infection.55 During the influenza A H1N1 epidemic in 2009, the disease was more critical and had a 2-fold longer duration in the patients with obesity who were then treated in intensive care units compared with the background population.56 People with obesity also have mechanical respiratory problems, with reduced ventilation of the basal lung sections increasing the risk of pneumonia as well as reduced oxygen saturation of blood.57

Diabetic complications, such as ischemic heart disease and diabetic kidney disease, may complicate the situation for people with diabetes, cuasing an increase of the severity of COVID-19 disease and the need for special care such as acute dialysis. Some studies show that COVID-19 could induce acute cardiac injury with heart failure, leading to deterioration of systemic circulation.58

Furthermore, inflammation plays a critical role in the progression of crystal-caused disease and can be seen in patients with particle-induced lung disease.59 A study from Dostert et al. has shown that exogenous particles such as asbestos (asbestosis) or crystalline silica (silicosis), activate the NLRP3 inflammasome.60 The NLRP3 inflammasome detects crystalline warning signs that can occur during autoinflammatory diseases, and environmental diseases, such as silicosis or asbestosis.61 Interleukin (IL) -1 cytokines are potent mediators of innate immunity in response to exposure to crystalline silica62 and have been implicated in the pathophysiology of human and experimental diseases.63

Damby demonstrated the propensity of volcanic cristobalite to activate the NLRP3 inflammasome, following a series of conclusive toxicological investigations of ash from recent major eruptions. The NLRP3 inflammasome has become a central mechanism in mediating cellular responses to various endogenous and exogenous signals and particles related to environmental and lifestyle diseases, given the established danger posed by respirable crystalline silica in occupational settings, the ability of volcanic ash to stimulate the release of IL-1β by macrophages in vitro, and the observation that the instigation of chronic crystalline silica disease depends on NLRP3.59,64

The researchers demonstrate that SARS-CoV-2 causes severe lung pathology by inducing pyroptosis,65 a highly inflammatory form of programmed cell death.66 This type of cell death is carried out by macrophages and other immune cells of the immune system causing symptoms such as lymphopenia67 that blocks an effective immune response to the virus.

As the molecular biology of SARS-CoV-2 is still being studied, inflammatory mechanisms similar to SARS-CoV-1 are known. A viral protein encoded by ORF8b interacts directly with the inflamasome NLRP3 (leucine-rich repeat of the nucleotide binding domain [NLR] and receptor 3 containing the pyrin domain),68 which activates the adapter protein ASC and caspases 4, 5, and 11. Simultaneously, it induces proinflammatory cytokines (eg, IL-1β and IL-18),69 Therefore, it is necessary to inhibit pyroptosis by acting on NLRP3 in the lungs. The mechanisms of inhibition of NLRP3 have been studied,70 and melatonin acts as an inflammasome inhibitor of NLRP3.71 In the bacterial pneumonia model, lipopolysaccharide (LPS) -induced mouse model, melatonin was shown to successfully inhibit pneumonia by interfering with the NLRP3 inflammasome, protecting macrophages from pyroptosis.72 Other publications also demonstrate that melatonin can be an effective inhibitor of pyroptosis and associated pathologies.73

Chong-Shan Shi et al. demonstrate that SARS-CoV can activate the NLRP3 inflammasome in macrophages through ORF8b. Although SARS-CoV abortively infects macrophages/monocytes, there may be enough ORF8b to affect the integrity of the lysosome, autophagy pathways, and NLRP3 inflammasomes. Unlike macrophages, SARS-CoV productively replicates in lung epithelial cells. These cells also express NLRP3 and can assemble NLRP3 inflammasomes. In humans infected with SARS-CoV, the full impact of ORF-8b on the pathways we delineated in this study is likely on the pulmonary epithelium. ORF8b may contribute to cytokine storm and inflammation activation that occurs during severe SARS-CoV infection.74 In the future, live virus clearance studies are required to assess the effects of ORF8b-mediated intracellular aggregates and ORF8b-mediated activation of NLRP3. However, here we identify novel mechanisms through which ORF8b can contribute to the pathogenesis of SARS.

In general, SARS-CoV-2 infection can be transmitted through respiratory droplets, which are 5-10 microns (µm) in diameter.5 According to the available data, the COVID-19 virus is transmitted mainly through contact with respiratory droplets75 from a person with respiratory symptoms (eg, cough or sneeze), the droplets gaining access through mucous membranes (mouth and nose) or conjunctiva (eyes). In addition, transmission can occur through fomites droplets in the immediate environment of a person infected.76 Airborne transmission of the COVID-19 virus may be possible in specific circumstances and locations where procedures are performed or treatments that can generate aerosols, such as endotracheal intubation, bronchoscopy, open aspiration, administration of a drug by nebulization, manual ventilation before intubation. However, there has been some evidence that the COVID-19 virus can cause intestinal infection and be present in feces,77 although no fecal-oral transmission has been reported.

Measures to avoid a contagion involve the following: correct, frequent hand washing with soap and water or with an alcohol-based hand sanitizer of at least 70%; keeping a distance of at least 2 meters (6 feet) from other persons, especially those who cough, sneeze, and have a fever; and disinfecting inanimate surfaces with disinfectants as often as possible.

The World Health Organization (WHO) has received reports of the existence of variants of SARS-CoV-2 that cause changes in transmissibility, clinical presentation, and severity, causing concern as to if there is an impact on the diagnosis, therapeutics, and protection from vaccines. Reports mentioning virus variants from the Kingdom of Denmark, the United Kingdom of Great Britain and Northern Ireland, and the Republic of South Africa have raised interest and concern about the impact of viral changes (Table 2).

Table 2.

Variants of the SARS-CoV-2 virus

Detection Name Mutations Date Transmisibility
United Kingdom B.1.1.7 69/70; 144Y; N501Y; A570D;D614G; P681H 14 Dec 2020 50%
South Africa B.1.351 K417N; E484K; N501Y; D614G Oct 2020 50%
Japan/Brazil P.1 E484K; K417N/T; N501Y; D614G Jan 2021 50%
California B.1.427/B.1.429 S13I, W152C and L452R Feb 2021 20%

These 4 variants share a specific mutation called D614G.78,79 This mutation provides the variants the ability to spread more rapidly than the prevailing viruses.80,81 As of December 30, 2020, variations have been reported in another 31 countries. Therefore, it is important that genomic surveillance be conducted to identify and characterize the variants of the virus and how these variants influence the severity of COVID 19 cases and the efficacy of vaccines and treatments. This is still being evaluated by the scientific community.8284

Volcanism and the Distribution of Volcanic Ash in Ecuador

Ecuador is a country with an extremely high density of volcanoes in its continental as well as insular territory.8587 The Galapagos archipelago, as a result of hot spot geodynamics, possesses more than 3000 mostly extinct volcanoes, while the Ecuadorian mainland has more than 250 volcanoes due to the subduction of the Nazca Plate below the South American continent.85,86 From the Galapagos, an aseismic ridge of extinct volcanoes, called Carnegie, is transported above the oceanic Nazca Plate toward the continent, where its subduction gives rise to the striking NNE-SSW volcanic chains of Ecuador.8890 In both environments, only a minor amount of the existing volcanoes are active, but their activity contemplates with a variety of volcanic hazards, including the massive emission of fine-grained volcanic ash, among other threats.91101 In continental Ecuador, there are 19 active volcanoes, of which 5 have been erupting in several occasions during the past 22 y.102 (Smithsonian Institution Global Volcanism Program, 2021). These 5 erupting volcanoes have been Sangay, Tungurahua, Guagua Pichincha, Reventador, and Cotopaxi (Figure 3). Sangay has a permanent activity with higher intensities in 2004-2011, 2013, and 2016 as well as strong intensities in 2018-2021.103 Tungurahua erupted after 80 y of tranquility in 1999 and continued erupting with minor interruptions until 2016.104 Guagua Pichincha has been occasionally erupting between 1999 and 2001 and again in 2009.105 The Reventador volcano erupted in 1976 and 2002 and continued with major interruptions until 2021, while Cotopaxi has been very active only in 2015.106,107

Figure 3.

Figure 3.

Main direction of volcanic ash distribution within a rose-diagram of the volcanoes Tungurahua (4412 satellite images), Reventador (2744), Sangay (1641), Cotopaxi (151), and Guagua Pichincha (31). All data are normalized to 100%, for each evaluated volcano.

In all these periods, all 5 volcanoes have emitted fine-grained volcanic ash in a variety of amounts and reach.97,98,108,109 Since September 1999, these eruptive phases have been observed from space due to the satellite imagery of the Satellite Services Division of the National Environmental Satellite, Data, and Information Service (NESDIS). Using the available data, the distribution of the volcanic ash has been traced in the corresponding areas of Ecuador, allowing evaluation of the areas experiencing the fallout of this volcanic hazard. Some 8703 satellite images gathered between September 1999 and January of 2021 have been evaluated, allowing characterization of the areas influenced by the volcanic ash precipitation. It is well known that vocanic ash fallout is the cause of a high amount of previously described health vulnerabilities and damage or interruptions of strategic infrastructure.98,101,108,110

Such fine-grained volcanic materials have a wide range of composition as well as morphologies due to a variety of processes during the rise of the magma and its subsequent fractionalization prior eruption.111113 We have taken samples at different, regular time periods of all active volcanoes of which some results have been published elsewhere.95,97,110

A field emission gun scanning electron microscope (FEG-SEM), brand TESCAN model MIRA3, was used to characterize all the samples. Chemical analysis was performed using the EDX technique with a BRUKER detector XFlash 6130, resolution 123 eV for Mn alpha. This was done using a double adhesive layer of carbon tape on SEM stubs. To ensure conductivity of the samples, morphology analysis was done applying a gold coating of around 20 nanometers using the sputter coater QUORUM Q150R. The main elements analyzed were Na, Mg, Al, Si, P, K, Ca, Ti, Mn, Fe. Other elements are present but at lower than the limit of detection. The compositions of ashes of Pichincha, Cotopaxi, Reventador, Sangay, and Tungurahua volcanoes are listed in Table 3. The elements Ti, P, and Mn have a percentage weight concentration lower than 1.5%.

Table 3.

Average weight percentages of each analyzed element in wt %, of all ash samples of the studied active volcanoes (Mn<1%, Ti and P<1.5%)

Si Al Ca Fe Na Mg K S
Pichincha 47.16 17.71 8.74 9.35 5.12 2.44 5.16 1.58
Cotopaxi 41.56 20.30 13.43 9.28 5.35 1.78 2.76 3.25
Tungurahua 45.09 17.20 10.92 10.65 4.91 2.37 4.35 1.45
Reventador 44.30 16.78 10.95 10.25 4.83 1.98 5.46 2.89
Sangay 41.06 16.67 14.20 8.64 6.03 2.77 3.90 2.58

All of the volcanic ashes had an Si composition greater than 40% wt; Si is an aggressive element for human lungs. SEM pictures showed that ashes are quite inhomogeneous in their morphology. The size of the particle determines the distance it travels, and the particles sampled ranged in size from nanometers to millimeters. As an example, from the most recent Cotopaxi eruption, particles ranged in size from 10 nm to 300 µm at 20 km distance from the crater, and a mean size 113.5 µm. Except of the Cotopaxi volcano, all other fine-grained pyroclastic material have been juvenile. The 101 days in 2015 of expulsion of volcanic ash from the Cotopaxi volcano has been exclusively of reworked material due to the fact that it has been originated by hydrothermal processes.95,97 Therefore, the reworked fine-grained pyroclastic material of the Cotopaxi volcano was of angular to sub-angular morphologies, while the predominant material of Sangay, Reventador, Guagua Pichincha, and Tungurahua volcanoes has been varied from rounded to sub-angular shapes.

The continental volcanoes of Ecuador are oriented perpendicular to the subduction zone along 4 NNE-SSW arcs, within the western volcanic cordillera, the Interandean Valley, the Cordillera Real, and the Subandean Basin. The evaluation of the distribution of fine-grained volcanic material of the 5 active volcanoes, based on 8979 satellite images (September 1999 – March 2021), indicates the predominant direction of travel to be mainly toward the west from their crater. Hereby, the predominant angle with above 60% of all possible directions of the ash distribution has been between 250 and 290 degrees (Figure 3). All other directions occur as well, but obviously to a minor degree, with the eastern directions being the very least of all. Volcanic ash fallout in southern regions and cities, such as Cuenca and Loja, or coastal cities, such as Guayaquil, occur occasionally, but less frequently; therefore, the areas are affected to a lesser extent (Figure 4).

Figure 4.

Figure 4.

Main direction and predominant reach of volcanic ashes (light gray colors) in Ecuador based on the activity of the volcanoes Tungurahua (TUN), Reventador (REV), Sangay (SAN), Cotopaxi (COT), and Guagua Pichincha (PIC), with the 3 most populated cities Quito (Q), Guayaquil (G), and Cuenca (C). Red triangles are further active volcanoes.

Not every contact with a coronavirus infected person leads to an infection, although the risk of transmitting the virus or its mutants, or even becoming infected, may vary due to a variety of situations. However, the dominant factor is the dose of the virus and certainly the closeness and time in contact with the an infected person.114 Therefore, it is a simple matter of time when in an area like Ecuador with very little or almost no preventive measures an increasing number of persons will be infected the coronavirus and its mutants. During a second or even third infection wave, the most vulnerable persons will have less and less opportunities to avoid contagions. The risk is particularly high if measures to reduce or limit the outbreak have been abandoned too early, due to countermeasures to avoid the increasing economic crisis as is occurring in Ecuador.115,116 Infection rates increase also because of a variety of reasons, such as fatigue, social and economic backgrounds, and a false sense of security among, many others. This phenomenon has been observed and documented worldwide.117119 Another fundamental aspect is based on the unsolved technical and economic issues in hospitals and their intensive care units, especially in Latin America. Such problems existed before the pandemic and have worsened since.120122

Based on the aforementioned data, a worsening of public health in areas in and close to volcanic ash emissions may be compared with that reported for air contaminated areas, which also increase vulnerability to the coronavirus.123125 The most affected Ecuadorian population, however, will be the persons who are living and working in the shadow of the ash fallout westward of the main concentration of the active volcanoes, being within the Highlands, the Inter-Andean Valley, and the coastal regions, as indicated in the current study (Figures 3-5). For those persons, it is imperative to protect them fromCOVID-19, even more so than people in areas with less contamination due to the absence of volcanic ash emissions.

Figure 5.

Figure 5.

The maps represent the monthly death rates per 100,000 inhabitants that have been standardized taking the official data of deaths published as of March 13, and the population data taken from the projections to the year 2019-2021 made by the INEC, using data from the Census of Population and Housing in 2010. The lowest mortality rates are represented in green and the highest in red, with yellow representing the average values according to the color code of the traffic light adopted by the Ecuadorian authorities.

Conclusions

SARS-CoV-2, which is transmitted in a variety of forms, is a deadly virus with a death rate of some 2.18% in respect to the infected amount of people.

Ecuador has been so far the second most affected country worldwide by the global COVID-19 pandemic, when counting deaths per million citizens based on the calculated excess mortality rates.

The precipitation of volcanic ash is responsible for a variety of health issues, particularly those involving the lungs and thyroid, areas that are preferentially affected by SARS-CoV-2 and the corresponding mutants.

Based on the evaluation of the geospatial distribution of the fine-grained volcanic ash, the continuous spreading wave of the virus and its mutants will most likely affect vulnerable persons westwards of the active volcanoes, within the Highlands, the Inter-Andean Valley, and the coastal regions of Ecuador. Therefore, based on this finding and forecast, a variety of preventive measures need to be implemented to protect this specific group of the total population.

References

  • 1. John Hopkins Coronavirus Research Center. COVID-19 data in motion. 2021. https://coronavirus.jhu.edu/. Accessed May 27, 2021.
  • 2. Worldometer. 2021. Coronavirus cases. https://www.worldometers.info/coronavirus/. Accessed May 27, 2021.
  • 3. Adams ML, Katz DL, Grandpre J. Population-based estimates of chronic conditions affecting risk for complications from coronavirus disease, United States. Emerg Infect Dis. 2020;26(8):1831. [DOI] [PMC free article] [PubMed]
  • 4. Ong SWX, Tan YK, Chia PY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020;323(16):1610-1612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. OMS (Organización Mundial de la Salud). Prevención y control de las infecciones respiratorias agudas con tendencia epidémica y pandémica durante la atención sanitaria. Ginebra: Organización Mundial de la Salud. 2014. https://www.paho.org/hq/dmdocuments/2014/2014-cha-prevencion-control-atencion-sanitaria.pdf. Accessed May 27, 2021.
  • 6. Smieszek T, Lazzari G, Salathé M. Assessing the dynamics and control of droplet- and aerosol-transmitted influenza using an indoor positioning system. Sci Rep. 2019;9(1):2185. doi: 10.1038/s41598-019-38825-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Schneider E, Bermingham A, Pebody R, et al. SRAS, MERS, and other coronavirus infections. In: Heymann DL, ed. Control of Communicable Diseases Manual. 20th ed. Washington, DC: American Public Health Association; 2016. [Google Scholar]
  • 8. Guo ZD, Wang ZY, Zhang SF, et al. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis. 2020;26(7):1583-1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Bahl P, Doolan C, de Silva C, et al. Airborne or droplet precautions for health workers treating COVID-19? J Infect Dis. 2020:jiaa189. [DOI] [PMC free article] [PubMed]
  • 10. Schuit M, Ratnesar-Shumate S, Yolitz J, et al. Airborne SRAS-CoV-2 is rapidly inactivated by simulated sunlight. J Infect Dis. 2020;222(4):564-571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(8):911-919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Cheng HY, Jian SW, Liu DP, et al. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020;180(9):1156-1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Wang Y, Tian H, Zhang L, et al. Reduction of secondary transmission of SRASCoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China. BMJ Glob Health. 2020;5(5):e002794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Guerra FM, Bolotin S, Lim G, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis. 2017;17(12):e420-e428. [DOI] [PubMed] [Google Scholar]
  • 15. Park M, Cook AR, Lim JT, et al. A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med. 2020;9(4):967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Anderson A. Dollarization: a case study of Ecuador. J Econ Dev Studies. 2016;4(2):56-60. [Google Scholar]
  • 17. Jin S-J, Lim S-Y, Yoo S-H. Causal relationship between oil consumption and economic growth in Ecuador. Energy Sources B: Econ Plan Policy. 2016;11(9):782-787. [Google Scholar]
  • 18. Toulkeridis T, Chunga K, Rentería W, et al. The 7.8 Mw earthquake and tsunami of the 16th April 2016 in Ecuador - Seismic evaluation, geological field survey and economic implications. Sci Tsunami Hazards. 2017;36:197-242 [Google Scholar]
  • 19. Wolff J. Ecuador after Correa: the struggle over the “Citizens’ Revolution”. Rev Cien Política. 2018;38(2):281-302. [Google Scholar]
  • 20. Hidrobo JA. Power and Industrialization in Ecuador. London: Routledge; 2019. [Google Scholar]
  • 21. Schodt DW. Ecuador: An Andean Enigma. London: Routledge; 2019. [Google Scholar]
  • 22. New York Times. The pandemics hidden toll: half a million deaths. 2020. https://www.nytimes.com/interactive/2020/04/21/world/coronavirus-missing-deaths.html?fbclid=IwAR3sC23cAHctdE7lpHIAq8Vxkaw0U0976Zh9QQZtF1Gocm1DEXjY8eWQabI. Accessed May 27, 2021.
  • 23. Heuveline P, Tzen M. Three CoViD-19 mortality indicators for temporal and international comparisons. medRxiv. 2020.04.29.20085506.
  • 24. Sornette D, Mearns E, Schatz M, et al. Interpreting, analysing and modelling COVID-19 mortality data. Nonlinear Dyn. 2020;1-26. [DOI] [PMC free article] [PubMed]
  • 25. Cepaluni G, Dorsch M, Branyiczki R. Political regimes and deaths in the early stages of the COVID-19 pandemic. SSRN. 2020. doi: 10.2139/ssrn.3586767 [DOI]
  • 26. El COMERCIO. Ecuador registra 25 519 muertes inusuales en cinco meses de pandemia. 2020. https://www.elcomercio.com/actualidad/ecuador-muertes-exceso-covid19-provincias.html?fbclid=IwAR1xS64gsz2plQtTlfZ5ukJDslyebsTCreSezWC8N0QiighyoahlBYA-6Mo. Accessed May 28, 2021.
  • 27. Instituto Nacional de Estadistica y Censos. Población y Demografía. 2021. https://www.ecuadorencifras.gob.ec/censo-de-poblacion-y-vivienda/. Accessed May 28, 2021.
  • 28. Cronin SJ, Stewart C, Zernack AV, et al. Volcanic ash leachate compositions and assessment of health and agricultural hazards from 2012 hydrothermal eruptions, Tongariro, New Zealand. J Volcanol Geotherm Res. 2014;286:233-247. [Google Scholar]
  • 29. Jenkins SF, Wilson TM, Magill C, et al. Volcanic ash fall hazard and risk. Glob Volcanic Hazards Risk. 2015;173-222.
  • 30. Bourne AJ, Abbott PM, Albert PG, et al. Underestimated risks of recurrent long-range ash dispersal from northern Pacific Arc volcanoes. Sci Rep. 2016;6(1):1-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Beck BD, Brain JD, Bohannon DE. The pulmonary toxicity of an ash sample from the Mt. St. Helens volcano. Exp Lung Res. 1981;2(4):289-301. [DOI] [PubMed] [Google Scholar]
  • 32. Yano E, Yokoyama Y, Nishii S. Chronic pulmonary effects of volcanic ash: an epidemiologic study. Arch Environ Health. 1986;41(2):94-99. [DOI] [PubMed] [Google Scholar]
  • 33. Buist AS, Vollmer WM, Johnson LR, et al. A four-year prospective study of the respiratory effects of volcanic ash from Mount St. Helens. Am Rev Respir Dis. 1986;133:526-534. [DOI] [PubMed] [Google Scholar]
  • 34. Baxter PJ, Ing R, Falk H, et al. Mount St. Helens eruptions: the acute respiratory effects of volcanic ash in a North American community. Arch Environ Health. 198338(3):138-143. [DOI] [PubMed]
  • 35. Kraemer MJ, McCarthy MM. Childhood asthma hospitalization rates in Spokane County, Washington: impact of volcanic ash air pollution. J Asthma. 1985;22(1):37-43. [DOI] [PubMed] [Google Scholar]
  • 36. Yano E, Yokoyama Y, Higashi H, et al. Health effects of volcanic ash: a repeat study. Arch Environ Health. 1990;45(6):367-373. [DOI] [PubMed] [Google Scholar]
  • 37. Gudmundsson G. Respiratory health effects of volcanic ash with special reference to Iceland. A review. Clin Respir J. 2011;5(1):2-9. [DOI] [PubMed] [Google Scholar]
  • 38. Arnbjörnsson E, Arnbjörnsson A, Ólafsson A. Thyroid cancer incidence in relation to volcanic activity. Arch Environ Health. 1986;41(1):36-40. [DOI] [PubMed] [Google Scholar]
  • 39. Buist AS. Evaluation of the short and long term effects of exposure to inhaled volcanic ash from Mt. St. Helens. In: Kagoshima International Conference on Volcanoes Proceedings. Tokyo: National Institute for Research Advancement; 1988;709-712. [Google Scholar]
  • 40. Russo M, Malandrino P, Addario WP, et al. Several site-specific cancers are increased in the volcanic area in Sicily. Anticancer Res. 2015;35(7):3995-4001. [PubMed] [Google Scholar]
  • 41. Sierra MS, Soerjomataram I, Forman D. Thyroid cancer burden in Central and South America. Cancer Epidemiol. 2016;44:S150-S157. [DOI] [PubMed] [Google Scholar]
  • 42. Salazar-Vega J, Ortiz-Prado E, Solis-Pazmino P, et al. Thyroid cancer in Ecuador, a 16 years population-based analysis (2001-2016). BMC Cancer. 2019;19(1):294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157-160. doi: 10.23750/abm.v91i1.9397 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Zheng YY, Ma YT, Zhang JY, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-260. doi: 10.1038/s41569-020-0360-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75(18):2352-2371. 10.1016/j.jacc.2020.03.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Lina B. Grippe. EMC - AKOS (Traité de Médecine). 2016;12(1):1-11. [Article 4-1200].
  • 47. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. South AM, Shaltout HA, Washburn LK, et al. Fetal programming and the angiotensin-(1–7) axis: a review of the experimental and clinical data. Clin Sci (Lond). 2019;133:55-74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Sparks MA, Crowley SD, Gurley SB, et al. Classical renin-angiotensin system in kidney physiology. Compr. Physiol. 2014;4:1201-1228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Alhogbani T. Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus. Ann Saudi Med. 2016;36(1):78-80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Wu Q, Zhou L, Sun X, et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;7(1):9110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Ferlita S, Yegiazaryan A, Noori N, et al. Type 2 diabetes mellitus and altered immune system leading to susceptibility to pathogens, especially mycobacterium tuberculosis. J Clin Med. 2019;8(12):2219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Critchley JA, Carey IM, Harris T, et al. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018;41:2127-2135. [DOI] [PubMed] [Google Scholar]
  • 55. Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. Int J Obes (Lond). 2013;37:333-340. [DOI] [PubMed] [Google Scholar]
  • 56. Honce R, Schultz-Cherry S. Impact of obesity on influenza a virus pathogenesis, immune response, and evolution. Front Immunol. 2019;10:1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12:755-767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5) doi: 10.1007/s00392-020-01626-9 [DOI] [PMC free article] [PubMed]
  • 59. Mossman BT, Glenn RE. Bioreactivity of the crystalline silica polymorphs, quartz and cristobalite, and implications for occupational exposure limits (OELs). Crit Rev Toxicol. 2013;43(8):632-660. doi: 10.3109/10408444.2013.818617 [DOI] [PubMed] [Google Scholar]
  • 60. Dostert C, Petrilli V, Van Bruggen R, et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320:674-677. doi: 10.1126/science.1156995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Hornung V, Bauernfeind F, Halle A, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008;9:847-856. doi: 10.1038/ni.1631 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Driscoll KE, Maurer JK. Cytokine and growth factor release by alveolar macrophages: potential biomarkers of pulmonary toxicity. Toxicol Pathol. 1991;19:398-405. doi: 10.1177/0192623391019004-108 [DOI] [PubMed] [Google Scholar]
  • 63. Huaux F. New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin Immunol. 2007;7:168-173. doi: 10.1097/ACI.0b013e32802bf8a5 [DOI] [PubMed] [Google Scholar]
  • 64. Damby DE, Horwell CJ, Baxter PJ, et al. (2018) Volcanic ash activates the NLRP3 inflammasome in murine and human macrophages. Front Immunol. 2018;8:2000. doi: 10.3389/fimmu.2017.02000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Yang M. Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection. SSRN. 2020:1-7. doi: 10.2139/ssrn.3527420 [DOI]
  • 66. Cookson BT, Brennan MA. Pro-inflammatory programmed cell death. Trends Microbiol. 2001;9(3):113-114. doi: 10.1016/S0966-842X(00)01936-3 [DOI] [PubMed] [Google Scholar]
  • 67. Panesar NS. Lymphopenia in SARS. Lancet. 2003;361(9373):1985. doi: 10.1016/S0140-6736(03)13557-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Shi C-S, Nabar NR, Huang N-N, et al. SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov. 2019;5:101. doi: 10.1038/s41420-019-0181-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Man SM, Karki R, Kanneganti T-D. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017;277(1):61-75. doi: 10.1111/imr.12534 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Zahid A, Li B, Kombe AJK, et al. Pharmacological Inhibitors of the NLRP3 Inflammasome. Front Immunol. 2019;10:2538. doi: 10.3389/fimmu.2019.02538 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Ma S, Chen J, Feng J, et al. Melatonin ameliorates the progression of atherosclerosis via mitophagy activation and NLRP3 inflammasome inhibition. Oxid Med Cell Longev. 2018;2018:9286458. doi: 10.1155/2018/9286458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Zhang Y, Li X, Grailer JJ, et al. Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome. J Pineal Res. 2016;60(4):405-414. doi: 10.1111/jpi.12322 [DOI] [PubMed] [Google Scholar]
  • 73. Wang X, Bian Y, Zhang R, et al. Melatonin alleviates cigarette smoke-induced endothelial cell pyroptosis through inhibiting ROS/NLRP3 axis. Biochem Biophys Res Commun. 2019;519(2):402-408. doi: 10.1016/j.bbrc.2019.09.005 [DOI] [PubMed] [Google Scholar]
  • 74. Shi C-S, Nabar NR, Huang N-N, et al. SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov. 2019;5:101. doi: 10.1038/s41420-019-0181-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Liu J, Liao X, Qian S, et al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China. 2020. Emerg Infect Dis. 2020;26(6):1320-1323. doi: 10.3201/eid2606.200239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Ng MY, Lee EY, Yang J, et al. Imaging profile of the COVID-19 infection: radiologic findings and literature review. Radiology: Cardiothoracic Imaging. 2019;2(1):e200034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Zhang Y, Chen C, Zhu S, et al. Isolation of 2019-nCoV from a stool specimen of a laboratory-confirmed case of the coronavirus disease 2019 (COVID-19). China CDC Weekly. 2020;2(8):123-124 [PMC free article] [PubMed] [Google Scholar]
  • 78. Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812-827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Zhang L, Jackson CB, Mou H, et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. BioRxiv 2020. doi: 10.1101/2020.06.12.148726. [DOI]
  • 80. Zhou B, Thao TTN, Hoffmann D, et al. SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility. bioRxiv. 2020.10.27. 357558. doi: 10.11/2020.10.27.357558
  • 81. Volz E, Hill V, McCrone J, et al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 2021;184:64-75. doi: 10.1/j.cell.2020.11.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Hartley PD, Tillett RL, AuCoin DP, et al. Genomic surveillance revealed prevalence of unique SARS-CoV-2 variants bearing mutation in the RdRp gene among Nevada patients. medRxiv. 2020;2020.08.21.20178863. [DOI] [PMC free article] [PubMed]
  • 83. Galloway SE, Paul P, MacCannell DR, et al. Emergence of SARS-CoV-2 b. 1.1.7 lineage—United States, December 29, 2020–January 12, 2021. MMWR Morb Mortal Wkly Rep. 2011;70(3):95-99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Quéromès G, Destras G, Bal A, et al. Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France. Emerg Microbes Infect. 2021;10(1):167-177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Toulkeridis T. Volcanic Galápagos Volcánico. (bilingual Spanish-English). Quito, Ecuador: Ediecuatorial; 2011. 364 pp.
  • 86. Toulkeridis T. Volcanes Activos Ecuador. Quito, Ecuador: Santa Rita; 2013. 152 pp [Google Scholar]
  • 87. Toulkeridis T, Angermeyer H. Volcanoes of the Galapagos. 2nd ed. Guayaquil, Ecuador: Abad Offest; 2019. 324 pp. [Google Scholar]
  • 88. Lonsdale P. Ecuadorian subduction system. AAPG Bull. 1978;62(12):2454-2477. [Google Scholar]
  • 89. Pennington WD. Subduction of the eastern Panama Basin and seismotectonics of northwestern South America. J Geophys Res Solid Earth. 1981;86(B11):10753-10770. [Google Scholar]
  • 90. Coltorti M, Ollier CD. Geomorphic and tectonic evolution of the Ecuadorian Andes. Geomorphology. 2000;32(1-2):1-19. [Google Scholar]
  • 91. Toulkeridis T, Buchwald, R , Addison A. when volcanoes threaten, scientists warn. Geotimes. 2007;52:36-39. [Google Scholar]
  • 92. Padrón E, Hernández PA, Marrero R, et al. Diffuse CO2 emission rate from the lake-filled Cuicocha and Pululagua calderas, Ecuador. J Volcanol Geothermal Res. 2008;176:163-169. [Google Scholar]
  • 93. Ridolfi F, Puerini M, Renzulli A, et al. The magmatic feeding system of El Reventador volcano (Sub-Andean zone, Ecuador) constrained by mineralogy, textures and geothermobarometry of the 2002 erupted products. J Volcanol Geothermal Res. 2008;176:94-106. [Google Scholar]
  • 94. Padrón E, Hernández PA, Pérez NM, et al. Fumarole/plume and diffuse CO2 emission from Sierra Negra volcano, Galapagos archipelago. Bull Volcanol. 2012;74:1509-1519. [Google Scholar]
  • 95. Toulkeridis T, Arroyo CR, Cruz D’Howitt M, et al. Evaluation of the initial stage of the reactivated Cotopaxi volcano - analysis of the first ejected fine-grained material. Nat Hazards Earth Syst Sci. 2015;3(11):6947-6976. [Google Scholar]
  • 96. Toulkeridis T. Unexpected results of a seismic hazard evaluation applied to a modern hydroelectric plant in central Ecuador. J Struct Eng. 2016;43(4):373-380. [Google Scholar]
  • 97. Vaca Mora A, Arroyo Rodriguez C, Debut A, et al. Characterization of fine-grained material ejected by the Cotopaxi volcano employing x-ray diffraction and electron diffraction scattering techniques. Biol Med. 2016;8(3):280. [Google Scholar]
  • 98. Toulkeridis T, Zach I. Wind directions of volcanic ash-charged clouds in Ecuador – implications for the public and flight safety. Geomatics Nat Hazards Risks. 2017;8(2):242-256. [Google Scholar]
  • 99. Rodriguez F, Toulkeridis T, Padilla O, et al. Economic risk assessment of Cotopaxi volcano Ecuador in case of a future lahar emplacement. Nat Hazards (Dordr). 2017;85(1):605-618. [Google Scholar]
  • 100. Parra R. Influence of spatial resolution in modeling the dispersion of volcanic ash in Ecuador. WIT Trans Ecol Environ. 2019;236:67-68. [Google Scholar]
  • 101. Echegaray-Aveiga RC, Rodríguez F, Toulkeridis T, et al. 2019. Effects of potential lahars of the Cotopaxi volcano on housing market prices. J Appl Volcanol. 2019;9:1-11.
  • 102. Smithsonian Institution Global Volcanism Program. 2021. https://volcano.si.edu/. Accessed May 28, 2021.
  • 103. Global Volcanism Program. Report on Sangay (Ecuador). In: Sennert SK, ed. Weekly Volcanic Activity Report, 20 January – 26 January 2021. Smithsonian Institution and US Geological Survey. [Google Scholar]
  • 104. Global Volcanism Program. Report on Cotopaxi (Ecuador). In: Sennert SK ed. Weekly Volcanic Activity Report, 24 August – 30 August 2016. Smithsonian Institution and US Geological Survey. [Google Scholar]
  • 105. Global Volcanism Program. Report on Guagua Pichincha (Ecuador). In: Sennert SK, ed. Weekly Volcanic Activity Report, 8 June – 14 June 2016. Smithsonian Institution and US Geological Survey. [Google Scholar]
  • 106. Global Volcanism Program. Report on Tungurahua (Ecuador). In: Sennert SK, ed. Weekly Volcanic Activity Report, 28 September – 4 October 2016. Smithsonian Institution and US Geological Survey. [Google Scholar]
  • 107. Global Volcanism Program. Report on Reventador (Ecuador). In: Sennert SK, ed. Weekly Volcanic Activity Report, 20 January – 26 January 2021. Smithsonian Institution and US Geological Survey. [Google Scholar]
  • 108. Toulkeridis T, Seqqat R, Torres M, et al. COVID-19 Pandemic in Ecuador: a health disparities perspective. Rev Salud Publica Colombia. 2021;22(3):1-5. [DOI] [PubMed] [Google Scholar]
  • 109. Aviles-Campoverde D, Chunga K, Ortiz-Hernández E, et al. Seismically induced soil liquefaction and geological conditions in the city of Jama due to the Mw7.8 Pedernales earthquake in 2016, NW Ecuador. Geosciences. 2021;11:20. [Google Scholar]
  • 110. Aguilera C, Viteri M, Seqqat R, et al. Biological impact of exposure to extremely fine-grained volcanic ash. J Nanotechnol. 2018. doi: 10.1155/2018/7543859 [DOI]
  • 111. Eichelberger JC. Silicic volcanism: ascent of viscous magmas from crustal reservoirs. Annu Rev Earth Planet Sci. 1995;23(1):41-63. [Google Scholar]
  • 112. Németh K, White JD, Reay A, et al. Compositional variation during monogenetic volcano growth and its implications for magma supply to continental volcanic fields. J Geol Soc London. 2003;160(4):523-530. [Google Scholar]
  • 113. Karbowska B, Zembrzuski W. Fractionation and mobility of thallium in volcanic ashes after eruption of Eyjafjallajökull (2010) in Iceland. Bull Environ Contam Toxicol. 2016;97(1):37-43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114. Ortiz-Prado E, Simbaña-Rivera K, Gomez-Barreno L, et al. Clinical, molecular and epidemiological characterization of the SARS-CoV2 virus and the coronavirus Disease 2019 (COVID-19): a comprehensive literature review. Diagn Microbiol Infect Dis. 2020;98(1):115094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115. Adams-Prassl A, Boneva T, Golin M, et al. (2020). The Impact of the Coronavirus Lockdown on Mental Health: Evidence from the US. Cambridge Working Papers in Economics 2037, Faculty of Economics, University of Cambridge. [Google Scholar]
  • 116. Friedman E, Friedman J, Johnson S, et al. Transitioning out of the coronavirus lockdown: a framework for zone-based social distancing. Front Public Health. 2020;8:266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117. Dubey S, Biswas P, Ghosh R, et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr. 2020;14(5):779-788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118. Heitzman J. Impact of COVID-19 pandemic on mental health. Psychiatr Pol. 2020;54(2):187-198. [DOI] [PubMed] [Google Scholar]
  • 119. Islam SMD, Bodrud-Doza M, Khan RM, et al. Exploring COVID-19 stress and its factors in Bangladesh: a perception-based study. Heliyon. 2020;6(7):e04399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next?. Lancet. 2020;395(10231):1225-1228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121. Rello J, Belliato M, Dimopoulos MA, et al. Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium. Anaesth Crit Care Pain Med. 2020;39(6):723-730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122. Sasangohar F, Jones SL, Masud FN, et al. Provider burnout and fatigue during the COVID-19 pandemic: lessons learned from a high-volume intensive care unit. Anesth Analg. 2020;131(1):106-111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123. Wu X, Nethery RC, Sabath BM, et al. Exposure to air pollution and COVID-19 mortality in the United States. MedRxiv. 2020;2020.04.05.20054502. [DOI] [PMC free article] [PubMed]
  • 124. Bontempi E. First data analysis about possible COVID-19 virus airborne diffusion due to air particulate matter (PM): the case of Lombardy (Italy). Environ Res. 2020;186:109639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125. Urrutia-Pereira M, Mello-da-Silva CA, Solé D. COVID-19 and air pollution: a dangerous association? Allergol Immunopathol (Madr). 2020;48(5):496-499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126. Ban-Nai, T , & Muramatsu, Y. (2003). Transfer factors of radioiodine from volcanic-ash soil (Andosol) to crops. Journal of radiation research, 44(1), 23-30. [DOI] [PubMed] [Google Scholar]

Articles from Disaster Medicine and Public Health Preparedness are provided here courtesy of Cambridge University Press

RESOURCES